Götz M. Richter
Directeur/Bestuurslid bij CeloNova BioSciences, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jason Cone | M | - |
CeloNova BioSciences, Inc.
 CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 jaar |
| Carl J. St. Bernard | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 5 jaar |
| Mark C. Bates | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Markus Hecker | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Erich Schlick | M | 72 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Paul Scigalla | M | 79 |
Ruprecht-Karls-Universität Heidelberg
| 32 jaar |
| Gerd Auffarth | M | 59 |
Ruprecht-Karls-Universität Heidelberg
| 13 jaar |
| Andreas Wentzensen | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Kathy Conner | F | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Robert W. Mason | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 jaar |
| Sara Carlile | F | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 jaar |
| Eugen Leo | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Ernst Biekert | M | 99 |
Ruprecht-Karls-Universität Heidelberg
| 56 jaar |
| Michael Heinz | M | 60 |
Ruprecht-Karls-Universität Heidelberg
| 7 jaar |
| Magnus von Knebel Döberitz | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Harry R. Jacobson | M | 76 |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Margret Suckale | F | 68 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Paul Kirchhof | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Thomas Lyles | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Thorlef Spickschen | M | 83 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Uwe Bicker | M | 79 |
Ruprecht-Karls-Universität Heidelberg
| 13 jaar |
| Mohsen M. Sohi | M | 65 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Malte Bahner | M | 61 |
Ruprecht-Karls-Universität Heidelberg
| - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Duitsland | 15 | 65.22% |
| Verenigde Staten | 8 | 34.78% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Götz M. Richter
- Persoonlijk netwerk
